| dc.contributor.author | Erdal, Seçkin | |
| dc.contributor.author | Sivrikaya, Sibel Karaca | |
| dc.contributor.author | Özdelikara, Afitap | |
| dc.contributor.author | Murray, John | |
| dc.date.accessioned | 2024-10-02T06:42:10Z | |
| dc.date.available | 2024-10-02T06:42:10Z | |
| dc.date.issued | 2023 | en_US |
| dc.identifier.isbn | 979-889113144-6, 979-889113089-0 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12462/15249 | |
| dc.description | Sivrikaya, Sibel Karaca (Balikesir Author) | en_US |
| dc.description.abstract | Hematopoietic stem cell transplantation (HSCT) is an important treatment modality that provides effective cure and improved survival rates for various hematologic and nonhematologic malignancies [1]. However, the intensive high-dose chemotherapy and radiotherapy used as conditioning therapy before transplantation often leads to significant side effects. Therefore, it is crucial to provide patients with comprehensive information prior to transplantation and to take the necessary precautions to minimize complications that may occur before, during, and after HSCT [2]. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Nova Science Publishers, Inc. | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Bone Marrow | en_US |
| dc.subject | Hematopoietic Stem Cells | en_US |
| dc.subject | Transplantation | en_US |
| dc.title | Hematopoietic stem cell transplantation | en_US |
| dc.type | bookPart | en_US |
| dc.relation.journal | Medical Nursing | en_US |
| dc.contributor.department | Sağlık Bilimleri Fakültesi | en_US |
| dc.identifier.startpage | 85 | en_US |
| dc.identifier.endpage | 90 | en_US |
| dc.relation.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
